A Duke Health research and clinical teams have confirmed a 2016 study that provides a method for sterilizing previously used N95 masks. Duke has built on the study by including fit testing after sterilization.

Officials at Duke have taken proactive steps to minimize health and safety risks to Duke students, faculty, staff and the larger community. They are providing advice and information at Duke’s Coronavirus Response website.

PIs of Duke research laboratories were asked to develop contingency plans in the event of a campus shutdown as a result of the COVID-19 outbreak. This message is to inform you that we must now implement these plans, which will severely curtail laboratory research activities on Duke’s campus and in our leased facilities.For more information visit Duke Research.

Duke CTSI has announced the winners of its 2018 Translational Accelerator Award RFA. Three projects have been selected for their outstanding potential to translate scientific discoveries into better outcomes in a clinical and population settings.

The awardees for the Translational Accelerator Awards (2019-2020 cycle) are:

Optical Assessment of Retinal Microvascular Ischemia in Cardiopulmonary Bypass
Principal Investigator: Cynthia Toth
Co-Investigators: Quintin Quinones, Sidney Gospe, Joseph Izatt, Christian Viehland, Sandra Stinnett

Sensitization of Pancreatic Cancer to Chemotherapy
Principal Investigator: Pei Zhou
Co-Investigators: Fan Yuan, Jiyong Hong

AAV Mediated Gene Therapy of A Mouse Model of Alternating Hemiplegia of Childhood
Principal Investigator: Mohamad Mikati
Co-Investigators: Boris Kantor, Dwight Koeberl

Duke professors Susan Alberts and Sue Jinks-Robertson have been elected to the U.S. National Academy of Sciences, which is widely considered one of the highest honors a scientist can receive.

Join us at the DCI Annual Scientific Retreat! We will be presenting a poster on the preclinical resource and will be available for questions/comments/suggestions.

http://sites.duke.edu/dukecancerinstitute/?p=4750

The Duke Preclinical Translational Research Unit has received 3 years funding from the School of Medicine as a new Core Research Facility with approval from Raphael Valdivia, PhD, Vice Dean for Basic Science. We are grateful to Dr. Valdivia and the support from the SOM.

The Duke Preclinical Translational Research Unit has received funding support from the Duke Cancer Institute as a pilot shared resource. We are grateful to Michael Kastan, MD, PhD, Executive Director of the Duke Cancer Institute, and Mark Dewhirst, DVM, PhD, Director of the DCI Shared Resources Oversight Committee for their support.